General Announcement for PLC

21/03/2022

NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY") BONUS ISSUE OF WARRANTS

SINARAN ADVANCE GROUP BERHAD

Type Announcement
Subject NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING
Description
SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY")

BONUS ISSUE OF WARRANTS

Abbreviations used herein shall be the same as those defined in the earlier announcements in relation to the Bonus Issue of Warrants.

 

On behalf of the Board, M&A Securities is pleased to announce that the Board has resolved to fix the exercise price for the Warrants at RM0.12 per Warrant (“Exercise Price”).

 

The Exercise Price was determined by the Board after taking into consideration, amongst others, the following:

 

(i)        the historical share price movement of SAG Shares and prevailing market conditions;

 

(ii)        the 5D-VWAMP of SAG Shares up to and including 18 March 2022 of RM0.0792 per Share, being the market day immediately preceding the date of this announcement; and

 

(iii)       the future funding requirements of the Group.

 

The Exercise Price represents a premium of approximately 51.5% to the 5D-VWAMP of SAG Shares up to and including 18 March 2022 of RM0.0792 per Share.

 

The Board is of the view that the Exercise Price is fair.

 

 

This announcement is dated 21 March 2022.






Announcement Info

Company Name SINARAN ADVANCE GROUP BERHAD
Stock Name SINARAN
Date Announced 21 Mar 2022
Category General Announcement for PLC
Reference Number GA1-21032022-00049


Related Announcements for SINARAN
Date Title
18/05/2022 MEMORANDUM OF UNDERSTANDING Sinaran Advance Group Berhad ("SAG" or the "Company") - Termination on Memorandum of Understanding ("MoU") entered into between Kanger International Berhad ("KIB") and K Star Healthcare Sdn. Bhd. ("K Star Healthcare"), a wholly-owned subsidiary of the Company ("the Parties") in relation to the Appointment of K Star Healthcare as the Sale Agent for Covid-19 vaccines in Malaysia
25/04/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY") BONUS ISSUE OF WARRANTS
22/04/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY") BONUS ISSUE OF WARRANTS
28/02/2022 MEMORANDUM OF UNDERSTANDING Sinaran Advance Group Berhad ("SAG" or the "Company") - Quarterly Update on Memorandum of Understanding ("MoU") entered into between Kanger International Berhad ("KIB") and K Star Healthcare Sdn. Bhd. (" K Star Healthcare"), a wholly-owned subsidiary of the Company ("the Parties") in relation to the Appointment of K Star Healthcare as the Sale Agent for Covid-19 vaccines in Malaysia
11/02/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : ESOS SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY") EMPLOYEES SHARE OPTION SCHEME ("ESOS")
11/02/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY") BONUS ISSUE OF WARRANTS
28/01/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY") BONUS ISSUE OF WARRANTS
14/01/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING SINARAN ADVANCE GROUP BERHAD ("SAG" OR "COMPANY") PRIVATE PLACEMENT OF 30% OF THE ISSUED ORDINARY SHARES IN SAG
03/01/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY") PRIVATE PLACEMENT OF UP TO 30% OF THE ISSUED ORDINARY SHARES IN SAG
30/11/2021 MEMORANDUM OF UNDERSTANDING Sinaran Advance Group Berhad ("SAG" or the "Company") Quarterly Update on Memorandum of Understanding ("MoU") entered into between Kanger International Berhad ("KIB") and K Star Healthcare Sdn. Bhd. ("K Star Healthcare") (the "Parties") in relation to the Appointment of K Star Healthcare, a wholly-owned subsidiary of SAG as the Sale Agent for Covid-19 vaccines in Malaysia